CEDAR REALTY TRUST, INC. (CDR) [Rocket]

Overview

CEDAR REALTY TRUST, INC. (CDR)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
08/10/2023	8-K	Submission of Matters to a Vote of Security Holders  Interactive Data
08/08/2023	8-K	Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits  I...
08/08/2023	10-Q	Quarterly Report for the period ended June 30, 2023
08/02/2023	8-K	Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
07/20/2023	8-K	Quarterly results
05/09/2023	8-K	Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits  I...
05/09/2023	10-Q	Quarterly Report for the period ended March 31, 2023

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14
Revenues	127.6	135.5	144.1	152.0	146.0	151.1	149.2	148.2
Revenue growth	-5.9%	-5.9%	-5.2%	4.1%	-3.4%	1.3%	0.7%	6.2%
Cost of goods sold	46.4	45.6	48.3	47.9	44.3	44.5	44.6	44.8
Gross profit	81.1	89.9	95.7	104.1	101.7	106.6	104.6	103.4
Gross margin	63.6%	66.4%	66.4%	68.5%	69.6%	70.5%	70.1%	69.8%
General and administrative	18.0	16.9	18.8	16.9	16.9	18.2	15.0	14.4
EBIT	-126.3	13.8	16.1	10.6	32.7	35.0	51.4	53.6
EBIT margin	-99.0%	10.2%	11.2%	7.0%	22.4%	23.2%	34.5%	36.2%
Pre-tax income	-45.0	-0.5	1.6	4.4	19.7	8.8	21.6	17.6
Income taxes	0.1	0.6	0.5	0.5	0.5	-0.2	-0.5	-11.4
Tax rate			31.3%	10.8%	2.6%
Earnings from continuing ops	-55.9	-11.8	-9.7	-10.5	-2.4	-5.5	7.6	3.5
Earnings from discontinued ops							0.2	11.1
Net income	-55.9	-11.8	-9.7	-10.5	-2.4	-5.5	7.7	14.6
Net margin	-43.8%	-8.7%	-6.7%	-6.9%	-1.6%	-3.6%	5.2%	9.8%

Diluted EPS	($4.23)	($0.90)	($0.74)	($0.78)	($0.03)	($0.07)	$0.09	$0.05
Shares outstanding (diluted)	13.2	13.1	13.1	13.4	84.2	81.7	81.4	75.3

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.